Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates
Open Access
- 28 August 2002
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 129 (3), 485-492
- https://doi.org/10.1046/j.1365-2249.2002.01925.x
Abstract
SUMMARY: Seeking better immunological markers indicating the long-term outcome of cystic echinococcosis (CE) after chemotherapy we studied 23 patients receiving albendazole, clinically followed for 8 years, and grouped ultrasonographically according to therapeutic outcome. Antibody responses against a partially purified fraction of hydatid fluid (HFF) and antigen B (AgB) were evaluated by indirect haemagglutination (IHA), ELISA and immunoblotting (IB). Although IHA titres varied over the course of treatment, differences in mean antibody titres to HFF between groups were significant only at 4 years (P = 0·031). IgG isotype expression remained unchanged during follow-up whereas IgE expression decreased in patients with cured or stable disease. AgB disclosed higher IgG4 expression (P < 10–4; P = 0·025) and lower IgG1 expression than HFF (P < 10–4; P = 0·022). IHA antibody titres were higher in patients with progressive than in those with cured or stable disease, even in those with the same cyst type. ELISA isotype profiles differed between groups, particularly for type CE 3, 4 and 5 cysts: higher serum IgG1 and IgG3, lower IgG4 and IgE in patients with cured or stable disease. Although combined serological testing provides scarce information on the long-term outcome of CE after chemotherapy it may be useful for reviewing in a retrospective study the outcome of a cyst and for assessing the host-parasite relationship.Keywords
This publication has 32 references indexed in Scilit:
- Modulation of Human Immune Response byEchinococcus granulosusAntigen B and Its Possible Role in Evading Host DefensesInfection and Immunity, 2001
- Evaluation of six serological tests in diagnosis and postoperative control of pulmonary hydatid disease patientsDiagnostic Microbiology and Infectious Disease, 1999
- Evaluation of human hydatid disease before and after surgery and chemotherapy by demonstration of hydatid antigens and antibodies in serumJournal of Medical Microbiology, 1997
- Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patientsParasite Immunology, 1996
- IgG Subclasses in Human Hydatid Disease: Prominence of the lgG4 ResponseInternational Archives of Allergy and Immunology, 1993
- Evaluation of a rapid dot-elisa as a field test for the diagnosis of cystic hydatid diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Mode of action of benzimidazolesParasitology Today, 1990
- Subunit composition and specificity of the major cyst fluid antigens of Echinococcus granulosusMolecular and Biochemical Parasitology, 1989
- Purification and partial characterization of the major antigen of Echinococcus granulosus (antigen 5) with monoclonal antibodiesMolecular and Biochemical Parasitology, 1986
- Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme‐immunoassayParasite Immunology, 1986